New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - alendronate sodium trihydrate 13.05mg equivalent to alendronate 10 mg;   - tablet - 10 mg - active: alendronate sodium trihydrate 13.05mg equivalent to alendronate 10 mg   excipient: magnesium stearate mannitol microcrystalline cellulose - for the treatment of paget's disease of bone in men and women

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - alendronate sodium trihydrate 52.2mg equivalent to alendronate 40 mg;   - tablet - 40 mg - active: alendronate sodium trihydrate 52.2mg equivalent to alendronate 40 mg   excipient: magnesium stearate mannitol microcrystalline cellulose - for the treatment of paget's disease of bone in men and women

New Zealand - English - Medsafe (Medicines Safety Authority)

aurobindo pharma nz limited - alendronate sodium trihydrate 91.363mg equivalent to alendronic acid 70 mg - tablet - 70 mg - active: alendronate sodium trihydrate 91.363mg equivalent to alendronic acid 70 mg excipient: magnesium stearate maize starch microcrystalline cellulose povidone sodium starch glycolate - indicated: in postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures). for the treatment of osteoporosis in men to prevent fractures.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - alendronate sodium trihydrate 91.37mg equivalent to alendronate 70mg; colecalciferol 140ug (5600 is vitamin d3);   - tablet - 70 mg/140 mcg - active: alendronate sodium trihydrate 91.37mg equivalent to alendronate 70mg colecalciferol 140ug (5600 is vitamin d3)   excipient: colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose - indicated for the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - alendronate sodium trihydrate 91.37mg equivalent to alendronate 70mg; colecalciferol 70ug (2800 iu vitamin d3);   - tablet - 70 mg/70 mcg - active: alendronate sodium trihydrate 91.37mg equivalent to alendronate 70mg colecalciferol 70ug (2800 iu vitamin d3)   excipient: colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose - indicated for the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - alendronate sodium, quantity: 91.35 mg (equivalent: alendronic acid, qty 70 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; macrogol 8000; carrageenan; magnesium stearate - treatment of osteoporosis, including glucocorticoid induced osteoporosis. osteoporosis must be confirmed by the finding of low bone mass of at least two standard deviations below the gender specific mean for young adults, or by the presence of osteoporotic fracture.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - alendronate sodium trihydrate 91.363mg equivalent to alendronic acid 70 mg - tablet - 70 mg - active: alendronate sodium trihydrate 91.363mg equivalent to alendronic acid 70 mg excipient: magnesium stearate maize starch microcrystalline cellulose povidone sodium starch glycolate - indicated: in postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures). for the treatment of osteoporosis in men to prevent fractures.

Canada - English - Health Canada

actavis pharma company - alendronic acid (alendronate sodium trihydrate) - tablet - 70mg - alendronic acid (alendronate sodium trihydrate) 70mg - bone resorption inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - alendronate sodium trihydrate 13.05mg equivalent to 10 mg alendronic acid - tablet - 10 mg - active: alendronate sodium trihydrate 13.05mg equivalent to 10 mg alendronic acid excipient: croscarmellose sodium lactose magnesium stearate microcrystalline cellulose

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - alendronate sodium trihydrate 6.53mg equivalent to 5 mg of alendronic acid - tablet - 5 mg - active: alendronate sodium trihydrate 6.53mg equivalent to 5 mg of alendronic acid excipient: croscarmellose sodium lactose magnesium stearate microcrystalline cellulose - fosamax is indicated: · in postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures). · in postmenopausal women who are at risk of developing osteoporosis fosamax is indicated for the prevention of osteoporosis to reduce the risk of future fracture. · for the treatment of osteoporosis in men to prevent fractures. · for the treatment and prevention of glucocorticoid-induced osteoporosis in men, premenopausal women and postmenopausal women receiving oestrogen. · for treatment of paget's disease of bone in men and women.